Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice

Hans E. Johnsen, Corrine Haioun, Pieternella J. Lugtenburg, Antonio Salar, Ulrich Jaeger, Ruth Pettengell, Francesca G. Rossi, Gregor Verhoef, Matthias Schwenkglenks, Kate Bendall, Ulrich Duehrsen

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)982-984
Number of pages3
JournalLeukemia and Lymphoma
Volume53
Issue number5
DOIs
Publication statusPublished - May 2012

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice. / Johnsen, Hans E.; Haioun, Corrine; Lugtenburg, Pieternella J.; Salar, Antonio; Jaeger, Ulrich; Pettengell, Ruth; Rossi, Francesca G.; Verhoef, Gregor; Schwenkglenks, Matthias; Bendall, Kate; Duehrsen, Ulrich.

In: Leukemia and Lymphoma, Vol. 53, No. 5, 05.2012, p. 982-984.

Research output: Contribution to journalArticle

Johnsen, Hans E. ; Haioun, Corrine ; Lugtenburg, Pieternella J. ; Salar, Antonio ; Jaeger, Ulrich ; Pettengell, Ruth ; Rossi, Francesca G. ; Verhoef, Gregor ; Schwenkglenks, Matthias ; Bendall, Kate ; Duehrsen, Ulrich. / Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice. In: Leukemia and Lymphoma. 2012 ; Vol. 53, No. 5. pp. 982-984.
@article{6d3771e96c97494885893f4c69c7e333,
title = "Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice",
author = "Johnsen, {Hans E.} and Corrine Haioun and Lugtenburg, {Pieternella J.} and Antonio Salar and Ulrich Jaeger and Ruth Pettengell and Rossi, {Francesca G.} and Gregor Verhoef and Matthias Schwenkglenks and Kate Bendall and Ulrich Duehrsen",
year = "2012",
month = "5",
doi = "10.3109/10428194.2011.643407",
language = "English",
volume = "53",
pages = "982--984",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor and Francis Ltd.",
number = "5",

}

TY - JOUR

T1 - Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice

AU - Johnsen, Hans E.

AU - Haioun, Corrine

AU - Lugtenburg, Pieternella J.

AU - Salar, Antonio

AU - Jaeger, Ulrich

AU - Pettengell, Ruth

AU - Rossi, Francesca G.

AU - Verhoef, Gregor

AU - Schwenkglenks, Matthias

AU - Bendall, Kate

AU - Duehrsen, Ulrich

PY - 2012/5

Y1 - 2012/5

UR - http://www.scopus.com/inward/record.url?scp=84859928396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859928396&partnerID=8YFLogxK

U2 - 10.3109/10428194.2011.643407

DO - 10.3109/10428194.2011.643407

M3 - Article

VL - 53

SP - 982

EP - 984

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 5

ER -